Search Results - Cihan Erol

Prognostic Significance of ARID1A, PTEN and PD-L1 Expressions and MMR Status in Colorectal Cancer Tissue by Seda KAHRAMAN, Sema Nur ÖZSAN ÇELEBİ, Ayça Dilşad KURATMER, İrfan KARAHAN, Didem Şener DEDE, Mehmet Ali Nahit ŞENDUR, Muhammed Bülent AKINCI, Cihan EROL, Mutlu HIZAL, Burak BİLGİN, Yakup ERGÜN, Fahriye Tuba KÖŞ, Hayriye Tatlı DOĞAN, Bülent YALÇIN

Get full text

The relationship between systemic immune inflammation index and survival in patients with metastatic renal cell carcinomatreated withtyrosine kinase inhibitors by Kadriye Bir Yücel, Emre Yekedüz, Serdar Karakaya, Deniz Tural, İsmail Ertürk, Cihan Erol, Özlem Ercelep, Nihan Şentürk Öztaş, Çağatay Arslan, Gökhan Uçar, Ahmet Küçükarda, Özlem Nuray Sever, Saadettin Kılıçkap, Orçun Can, Satı Coşkun Yazgan, Berna Öksüzoğlu, Nuri Karadurmuş, Mehmet Ali Şendur, Yüksel Ürün

Get full text

Bevacizumab versus aflibercept with FOLFIRI after FOLFOX and bevacizumab in RAS mutant metastatic colon cancer a Turkish oncology group study by Serhat Sekmek, Sema Nur Ozsan Çelebi, Dogan Bayram, Cihan Erol, Fahriye Tugba Kos, Mehmet Ali Nahit Sendur, Yunus Emre Altıntas, Tugba Tuylu, Sedat Yildirim, Sedat Biter, Mehmet Mutlu Kıdı, Ertugrul Bayram, Nargiz Majidova, Ibrahim Vedat Bayoglu, Mehmetcan Atak, Kadriye Baskurt, Sinem Akbas, Ali Alkan, Ayberk Bayramgil, Ferit Aslan, Elif Sahin, Onur Yazdan Balcik, Ahmet Ziya Bayhan, Seray Saray, Erkan Arpaci, Yakup Ergun

Get full text

First-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal junction cancer by Selin Aktürk Esen, Yakup Ergun, Cihan Erol, Rukiye Arikan, Muhammed Muhiddin Er, Muhammed Mustafa Atci, Atakan Topçu, Gökhan Uçar, Baran Akagündüz, Musa Bariş Aykan, Miraç Özen, Naziyet Köse Baytemur, Melike Özçelik, Elif Şahin, Denizcan Güven, Serkan Menekşe, Naziye Ak, Fatih Teker, Engin Kut, Teoman Şakalar, Özkan Alan, Turgut Kaçan, Nazim Serdar Turhal, Saadettin Kiliçkap, Sema Türker, Mehmet Ali Nahit Şendur, Osman Köstek, Mustafa Karaağaç, Abdullah Sakin, Haci Mehmet Türk, Dilek Çağlayan, Şener Cihan, Yusuf Açikgöz, Doğan Uncu

Get full text

Treatment outcomes and prognostic factors in patients with driver mutant non-small cell lung cancer and de novo brain metastases by Seda Kahraman, Serdar Karakaya, Muhammed Ali Kaplan, Sema Sezgin Goksu, Akin Ozturk, Zehra Sucuoglu Isleyen, Jamshid Hamdard, Sedat Yildirim, Tolga Dogan, Selver Isik, Abdussamet Celebi, Burcu Belen Gulbagci, Nail Paksoy, Mutlu Dogan, Haci Mehmet Turk, Ahmet Bilici, Ali Murat Tatli, Sinem Akbas, Nedim Turan, Ilhan Hacibekiroglu, Gamze Gokoz Dogu, Adnan Aydiner, Ahmet Taner Sumbul, Serap Akyurek, Merih Yalciner, Ahmet Demirkazik, Pinar Gursoy, Musa Baris Aykan, Elif Sahin, İbrahim Karadag, Osman Kostek, Muhammed Muhiddin Er, Mehmet Artaç, Yakup Duzkopru, Dincer Aydin, Deniz Isik, Yusuf Karakas, Saadettin Kilickap, Cihan Erol, Bilgin Demir, Burak Civelek, Yakup Ergun, Muhammed Bulent Akinci, Izzet Dogan, Nuri Karadurmus, Perran Fulden Yumuk, Mehmet Ali Nahit Sendur

Get full text

Real-world outcomes of trastuzumab deruxtecan in patients with HER2+ metastatic breast cancer: Turkish oncology group multicenter study by Taha Koray Sahin, Fatih Kemik, Harun Muglu, Bedriye Acikgöz Yildiz, Sedat Biter, Salih Tunbekici, Ahmet Oruc, Ali Kaan Guren, Kerim Kaban, Halil Goksel Guzel, Cihan Erol, Musa Baris Aykan, Bahadir Koylu, Omer Burak Ekinci, Ilknur Deliktas Onur, Ali Kalem, Oguz Altunok, Mustafa Seyyar, Bunyamin Guney, Orhun Akdogan, Rashad Ismayilov, Fadime Sinem Ardic, Melike Yazici, Nargiz Majidova, Sema Turker, Ece Esin, Devrim Cabuk, Hatime Arzu Yasar, Arzu Oguz, Ozan Yazici, Riza Umar Gursu, Mesut Yılmaz, Havva Yesil Cinkir, Ozturk Ates, Emir Celik, Nuri Karadurmus, Umut Demirci, Banu Ozturk, Nil Molinas Mandel, Ibrahim Vedat Bayoglu, Murat Araz, Erdem Goker, Ertugrul Bayram, Dilek Erdem, Fatih Selcukbiricik, Gul Basaran, Ahmet Sezer, Gamze Gokoz Dogu, Yasemin Kemal, Ahmet Bilici, Seyda Gunduz, Deniz Can Guven, Sercan Aksoy

Get full text